-
ESB Professional/Shutterstock.com -
wavebreakmedia/Shutterstock.com -
Syda Productions/Shutterstock.com -
iStock.com/shotsstudio
News
IMI's next Call for proposals is set to feature topics on cancer, tuberculosis, psoriasis, drugs based on proteins, and vaccines. This call is currently planned for January 2020.
The full list of topics currently being considered for inclusion in IMI2 – Call 20 and the draft texts can be viewed on the IMI Website
The EU Commission has published the presentations and webstreams of the Open InfoDay on "Health, demographic change and wellbeing" from 03.07.2019
Take a look at the EC-Website
Taking place in the iconic venue KANAL-Centre Pompidou, Quai des Péniches, Brussels, Belgium, the event aims to gather Europe’s researchers, scientists, innovators and policy makers. The event, which is open to everyone and is free of charge, will feature three main elements: a high-level Policy Conference, the Innovative Europe Hub and the ‘Science is Wonderful’ exhibition of EU-funded projects. This event will be an important part of the strategic planning process that sets the foundations for the first work programmes of Horizon Europe, the proposed €100 billion next EU programme for research and innovation (2021-2027).
The European Commission has pre-published the SC1 Work Programme 2020! Take a look at the upcoming calls and contact your national NCP for advice.
You can find the download on the Website of the EU Commission
The registration for the Horizon 2020 Health Partnering Day 2019 event organized by HNN 2.0 has been extended untill June 4th.
Register now and take the opportunity to build up a network for your Horizon 2020 proposal!
The Innovative Medicines Initiative is planning to launch IMI2 – Call 18 and 19 on 26 June 2019 with the following topics:
IMI2 – Call 18:
- Central repository of digital pathology slides to support the development of artificial intelligence tools;
- Health Outcomes Observatories – empower patients with tools to measure their outcomes in a standardised manner creating transparency of health outcomes;
- Improving patient access, understanding and adherence to healthcare information: an integrated digital health information project;
- Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials;
- Accelerating research & development for advanced therapy medicinal products;
- Supporting the development of chimeric antigen receptor T cells.
IMI2 – Call 19: Restricted Call
This is a single stage restricted Call for proposals designed to support further research activities to allow existing successful IMI consortia to build on the achievements of their initial action, move onto the next step of the research challenge, and maximise the impacts of the initial action results. For more information, please visit the IMI Future Topics page
Draft topic texts are available on the IMI Future Topics page.
The IMI2 Partnering Platform (set up by the German National Contact Point Life Sciences with support from the German Federal Ministry of Education and Research) has now been updated with the future topics foreseen for the 18th IMI2 Call. Information regarding IMI 2 future Calls for proposals is indicative and subject to the agreement of the IMI2 Governing Board on the Call topics.
The Platform provides networking opportunities to prepare for future IMI2 Calls. Drafts of the topics currently under consideration for inclusion in future IMI Calls for proposals can be found on the IMI-Website.
The IMI2 Partnering Platform allows potential IMI2 applicants to identify suitable cooperation partners for the 18th Call of the Innovative Medicines Initiative2. The IMI2 Partnering Platform does not only facilitate the quick and targeted search for possible partners but also displays European-wide cooperation offers specific to IMI2.
Networking via the Platform is open to all IMI2 applicants on the European level.
Research and Innovation: What's New in Health and life sciences
SC1 related programs
